Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hedy Teppler

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial dataRichard M Gesser, Kathleen McCarroll, Hedy Teppler, et al.
Surgical Infections|April 17, 2003
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactamHedy Teppler, Kathleen McCarroll, Richard M Gesser, et al.
Contemporary Clinical Trials|April 15, 2021
Design of a Phase III immunogenicity and safety study evaluating two-dose regimens of 9-valent human papillomavirus (9vHPV) vaccine with extended dosing intervalsHedy Teppler, Oliver Bautista, , et al.
Surgical Infections|April 17, 2003
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infectionsJose Tellado, Gail L Woods, Richard Gesser, et al.
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|October 9, 2003
[New Beta-lactam agent in the treatment of intra-abdominal sepsis: double blind and randomized stage III study of ertapenem versus piperacillin/tazobactam]Eduardo Barboza, Joseph Solomkin, E J Goldstein, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infectionBarbara A Pelak, Diane M Citron, Mary Motyl, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adultsAlbert E Yellin, James M Hassett, Alvaro Fernandez, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactamJoseph Solomkin, Hedy Teppler, Donald R Graham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110Diana F Clarke, Mark Mirochnick, Edward P Acosta, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infectionsMark J DiNubile, Joseph W Chow, Vilas Satishchandran, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial dataRichard M Gesser, Kathleen McCarroll, Hedy Teppler, et al.
Surgical Infections|April 17, 2003
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactamHedy Teppler, Kathleen McCarroll, Richard M Gesser, et al.
Contemporary Clinical Trials|April 15, 2021
Design of a Phase III immunogenicity and safety study evaluating two-dose regimens of 9-valent human papillomavirus (9vHPV) vaccine with extended dosing intervalsHedy Teppler, Oliver Bautista, , et al.
Surgical Infections|April 17, 2003
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infectionsJose Tellado, Gail L Woods, Richard Gesser, et al.
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|October 9, 2003
[New Beta-lactam agent in the treatment of intra-abdominal sepsis: double blind and randomized stage III study of ertapenem versus piperacillin/tazobactam]Eduardo Barboza, Joseph Solomkin, E J Goldstein, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infectionBarbara A Pelak, Diane M Citron, Mary Motyl, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adultsAlbert E Yellin, James M Hassett, Alvaro Fernandez, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactamJoseph Solomkin, Hedy Teppler, Donald R Graham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110Diana F Clarke, Mark Mirochnick, Edward P Acosta, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infectionsMark J DiNubile, Joseph W Chow, Vilas Satishchandran, et al.
Pageof 7